Ibandronate Suppresses Changes in Apatite Orientation and Young's Modulus Caused by Estrogen Deficiency in Rat Vertebrae
- PMID: 34989822
- PMCID: PMC9108105
- DOI: 10.1007/s00223-021-00940-2
Ibandronate Suppresses Changes in Apatite Orientation and Young's Modulus Caused by Estrogen Deficiency in Rat Vertebrae
Abstract
Bone material quality is important for evaluating the mechanical integrity of diseased and/or medically treated bones. However, compared to the knowledge accumulated regarding changes in bone mass, our understanding of the quality of bone material is lacking. In this study, we clarified the changes in bone material quality mainly characterized by the preferential orientation of the apatite c-axis associated with estrogen deficiency-induced osteoporosis, and their prevention using ibandronate (IBN), a nitrogen-containing bisphosphonate. IBN effectively prevented bone loss and degradation of whole bone strength in a dose-dependent manner. The estrogen-deficient condition abnormally increased the degree of apatite orientation along the craniocaudal axis in which principal stress is applied; IBN at higher doses played a role in maintaining the normal orientation of apatite but not at lower doses. The bone size-independent Young's modulus along the craniocaudal axis of the anterior cortical shell of the vertebra showed a significant and positive correlation with apatite orientation; therefore, the craniocaudal Young's modulus abnormally increased under estrogen-deficient conditions, despite a significant decrease in volumetric bone mineral density. However, the abnormal increase in craniocaudal Young's modulus did not compensate for the degradation of whole bone mechanical properties due to the bone loss. In conclusion, it was clarified that changes in the material quality, which are hidden in bone mass evaluation, occur with estrogen deficiency-induced osteoporosis and IBN treatment. Here, IBN was shown to be a beneficial drug that suppresses abnormal changes in bone mechanical integrity caused by estrogen deficiency at both the whole bone and material levels.
Keywords: Apatite orientation; Bone quality; Ibandronate; Material anisotropy; Mechanical integrity; Osteoporosis.
© 2021. The Author(s).
Conflict of interest statement
TN and MS have received research support from Chugai Pharmaceutical Co., Ltd. YM is an employee of Chugai Pharmaceutical Co., Ltd. RO and TI have no competing interests to declare that are relevant to the content of this article.
Figures








Similar articles
-
Combination treatment with ibandronate and eldecalcitol prevents osteoporotic bone loss and deterioration of bone quality characterized by nano-arrangement of the collagen/apatite in an ovariectomized aged rat model.Bone. 2022 Apr;157:116309. doi: 10.1016/j.bone.2021.116309. Epub 2022 Jan 5. Bone. 2022. PMID: 34998980
-
Osteoporosis Changes Collagen/Apatite Orientation and Young's Modulus in Vertebral Cortical Bone of Rat.Calcif Tissue Int. 2019 Apr;104(4):449-460. doi: 10.1007/s00223-018-0508-z. Epub 2018 Dec 26. Calcif Tissue Int. 2019. PMID: 30588540
-
Adaptive enhancement of apatite crystal orientation and Young's modulus under elevated load in rat ulnar cortical bone.Bone. 2024 Apr;181:117024. doi: 10.1016/j.bone.2024.117024. Epub 2024 Jan 23. Bone. 2024. PMID: 38266952
-
[Anisotropic crystallization of biominerals].Clin Calcium. 2014 Feb;24(2):193-202. Clin Calcium. 2014. PMID: 24473352 Review. Japanese.
-
Young's modulus of trabecular bone at the tissue level: A review.Acta Biomater. 2018 Sep 15;78:1-12. doi: 10.1016/j.actbio.2018.08.001. Epub 2018 Aug 4. Acta Biomater. 2018. PMID: 30081232 Review.
References
-
- Global Osteoporosis Drugs Market Size, Share, Development, Growth and Demand Forecast to 2022 – Industry Insights by Drug Class (Bisphosphonates, Parathyroid Hormone Therapy, Selective Estrogen Receptor Modulators, Rank Ligand Inhibitor, Calcitonin and Others. https://www.psmarketresearch.com/market-analysis/osteoporosis-drugs-market. Accessed 20 Oct, 2021
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical